Literature DB >> 29027117

Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation.

Mikiko Sakuragi1, Satoru Hayashi1, Miho Maruyama2, Tomoko Kiyokawa1, Keisuke Nagamine1, Jiro Fujita3, Tetsuo Maeda3, Hisashi Kato1,3, Hirokazu Kashiwagi3, Yuzuru Kanakura3, Yoshiaki Tomiyama4,5.   

Abstract

We consecutively examined the utility of measurements of percentage of immature platelet fraction (IPF%) and absolute IPF number (A-IPF) in predicting thrombopoietic recovery in 15 adult patients who underwent allogeneic hematopoietic stem cell transplantation (allo-SCT). Four patients were excluded from the evaluation due to insufficient data. Platelet count and IPF were measured by Sysmex XN-1000 (XN), a newer generation analyzer. First, we confirmed that platelet count measured by XN was more accurate than by XE-2100 (XE). IPF measurement was effective to predict the recovery in 7 of the 11 patients examined. Moreover, IPF measurement, especially IPF% measurement, suggested accelerated platelet turnover in two patients who failed to achieve platelet recovery by day 60. In addition to IPF%, A-IPF showed a complementary role on the prediction of thrombopoietic recovery. The increase in IPF% was only transient, while A-IPF values showed lasting increase during platelet recovery. In two patients (cases 6 and 7) an increase in A-IPF, but not in IPF%, was observed during platelet recovery. Our data suggest that IPF% and A-IPF measured by XN are useful for the prediction of thrombopoietic recovery and the assessment of pathogenesis of thrombocytopenia in patients after allo-SCT.

Entities:  

Keywords:  A-IPF; Allo-SCT; Engraftment; IPF%; TMA

Mesh:

Substances:

Year:  2017        PMID: 29027117     DOI: 10.1007/s12185-017-2344-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation.

Authors:  G Yamaoka; Yoshitsugu Kubota; T Nomura; T Inage; T Arai; A Kitanaka; K Saigo; K Iseki; N Baba; T Taminato
Journal:  Int J Lab Hematol       Date:  2010-12       Impact factor: 2.877

2.  Quantitation of reticulated platelets: methodology and clinical application.

Authors:  E M Richards; T P Baglin
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

3.  Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study.

Authors:  M Kuwana; Y Kurata; K Fujimura; K Fujisawa; H Wada; T Nagasawa; S Nomura; T Kojima; H Yagi; Y Ikeda
Journal:  J Thromb Haemost       Date:  2006-09       Impact factor: 5.824

4.  Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation.

Authors:  A Takami; M Shibayama; M Orito; M Omote; H Okumura; T Yamashita; S Shimadoi; T Yoshida; S Nakao; H Asakura
Journal:  Bone Marrow Transplant       Date:  2007-03-05       Impact factor: 5.483

5.  Predictive value of immature reticulocyte and platelet fractions in hematopoietic recovery of allograft patients.

Authors:  A P Gonçalo; I L Barbosa; F Campilho; A Campos; C Mendes
Journal:  Transplant Proc       Date:  2011 Jan-Feb       Impact factor: 1.066

6.  Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders.

Authors:  Mikiko Sakuragi; Satoru Hayashi; Miho Maruyama; Osamu Kabutomori; Tomoko Kiyokawa; Keisuke Nagamine; Hisashi Kato; Hirokazu Kashiwagi; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2015-01-25       Impact factor: 2.490

7.  Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation.

Authors:  H Michur; K Maślanka; A Szczepiński; B Mariańska
Journal:  Int J Lab Hematol       Date:  2008-12       Impact factor: 2.877

8.  Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation.

Authors:  Giovanna Martinelli; Patrizia Merlo; Rita Fantasia; Francesco Gioia; Giovanni Crovetti
Journal:  Transfus Apher Sci       Date:  2009-04-23       Impact factor: 1.764

9.  Platelet transfusion: a clinical practice guideline from the AABB.

Authors:  Richard M Kaufman; Benjamin Djulbegovic; Terry Gernsheimer; Steven Kleinman; Alan T Tinmouth; Kelley E Capocelli; Mark D Cipolle; Claudia S Cohn; Mark K Fung; Brenda J Grossman; Paul D Mintz; Barbara A O'Malley; Deborah A Sesok-Pizzini; Aryeh Shander; Gary E Stack; Kathryn E Webert; Robert Weinstein; Babu G Welch; Glenn J Whitman; Edward C Wong; Aaron A R Tobian
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

10.  Immature platelet fraction measured on the Sysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantation.

Authors:  Noreen van der Linden; Lieke J J Klinkenberg; Steven J R Meex; Erik A M Beckers; Norbert C J de Wit; Lenneke Prinzen
Journal:  Eur J Haematol       Date:  2014-04-25       Impact factor: 2.997

View more
  1 in total

1.  Assessment of haematopoietic progenitor cell counting with the Sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells.

Authors:  Francesco Dima; Erika Barison; Martina Midolo; Fabio Benedetti; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2019-07-25       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.